Literature DB >> 26599981

Can a simple test of functional capacity add to the clinical assessment of diabetes?

T Stewart1, D G Caffrey1, R H Gilman2,3, S C Mathai1, A Lerner2, A Hernandez4, M E Pinto4,5, Y Huaylinos4, L Cabrera3, R A Wise1, J J Miranda5,6, W Checkley1,2.   

Abstract

AIM: To identify impairment in functional capacity associated with complicated and non-complicated diabetes using the 6-min walk distance test.
METHODS: We enrolled 111 adults, aged ≥40 years, with Type 2 diabetes from a hospital facility and 150 healthy control subjects of similar age and sex from a community site in Lima, Peru. All participants completed a 6-min walk test.
RESULTS: The mean age of the 261 participants was 58.3 years, and 43.3% were male. Among those with diabetes, 67 (60%) had non-complicated diabetes and 44 (40%) had complications such as peripheral neuropathy, retinopathy or nephropathy. The mean unadjusted 6-min walk distances were 376 m and 394 m in adults with and without diabetes complications, respectively, vs 469 m in control subjects (P<0.001). In multivariable regression, the subjects with diabetes complications walked 84 m less far (95% CI -104 to -63 m) and those without complications walked 60 m less far (-77 to -42 m) than did control subjects. When using HbA1c level as a covariate in multivariable regression, participants walked 13 m less far (-16.9 to -9.9 m) for each % increase in HbA1c .
CONCLUSIONS: The subjects with diabetes had lower functional capacity compared with healthy control subjects with similar characteristics. Differences in 6-min walk distance were even apparent in the subjects without diabetes complications. Potential mechanisms that could explain this finding are early cardiovascular disease or deconditioning.
© 2015 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26599981      PMCID: PMC4955604          DOI: 10.1111/dme.13032

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  30 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  A SIMPLE FIELD TEST FOR THE ASSESSMENT OF PHYSICAL FITNESS. REP 63-6.

Authors:  B BALKE
Journal:  Rep Civ Aeromed Res Inst US       Date:  1963-04

3.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

4.  Progression of symptoms and functioning among female cardiac patients with and without diabetes.

Authors:  Mary R Janevic; Nancy K Janz; Cathleen M Connell; Niko Kaciroti; Noreen M Clark
Journal:  J Womens Health (Larchmt)       Date:  2010-11-22       Impact factor: 2.681

5.  The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease.

Authors:  Anne E Holland; Linda Nici
Journal:  Am J Respir Crit Care Med       Date:  2013-02-15       Impact factor: 21.405

Review 6.  Type 2 diabetes mellitus, pandemic in 21st century.

Authors:  Emil Ginter; Vlado Simko
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

7.  Screening for slight albuminuria: a comparison of selected commercially available methods.

Authors:  B T Williams; C H Ketchum; C A Robinson; D S Bell
Journal:  South Med J       Date:  1990-12       Impact factor: 0.954

8.  Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length.

Authors:  Frank Sciurba; Gerard J Criner; Shing M Lee; Zab Mohsenifar; David Shade; William Slivka; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

9.  Functional impairment in Mexican Americans and non-Hispanic whites with diabetes.

Authors:  B D Mitchell; M P Stern; S M Haffner; H P Hazuda; J K Patterson
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

10.  Pathobiochemical changes in diabetic skeletal muscle as revealed by mass-spectrometry-based proteomics.

Authors:  Kay Ohlendieck
Journal:  J Nutr Metab       Date:  2012-02-29
View more
  1 in total

1.  Variations in subclinical left ventricular dysfunction, functional capacity, and clinical outcomes in different heart failure aetiologies.

Authors:  Ying Wang; Hong Yang; Mark Nolan; Faraz Pathan; Kazuaki Negishi; Thomas H Marwick
Journal:  ESC Heart Fail       Date:  2018-02-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.